Welcome to the two-vaccine conundrum.
Doctors have their stories to tell about mental illness. But what about the stories we tell ourselves?
Prepare yourself for a lifetime of fall vaccine campaigns.
An unnerving flu season in the Southern Hemisphere bodes poorly for those in the north.
If the drug becomes significantly cheaper than newer, better diabetes treatments, more people could die from the disease.
“Vaccines are super important, but they can’t do this job alone.”
The agency I used to lead is beset by slowness, impracticality, and lack of strategic thinking—but its mission is too essential to abandon.
Declaring victory over a disease is easier than meeting survivors’ needs.
For much of the pandemic, Americans put off nonemergency health care. That could haunt us for years to come.
Droughts, pests, and slim margins threaten farmers’ mental health. To help, five states are piloting a unique hotline.
The key ingredient in our oldest vaccine is a mystery that goes back 200 years.
New boosters that target Omicron may be our most important COVID vaccines since 2020—but the U.S. may be setting up the new shots to fail.
The administration’s newest vaccine Hail Mary may not be enough to fix the U.S.’s monkeypox immunization problems.
A year after he was banned, Alex Berenson sued his way back. Are more lawsuits coming?
How I went from telemedicine skeptic to advocate
Public-health officials don’t need to tiptoe around how monkeypox is currently being transmitted.
Will splitting monkeypox vaccines in five work out?
Scientists try to protect children and pregnant women from harm, but exclusion from early research carries a cost.
Americans love it. But the science is getting even weirder.
The U.S. has declared (another) public-health emergency. An expert weighs in on whether we might botch this one, too.